HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).

Attendees

Agenda Items and Notes

Meeting Notes from previous meeting

• 2021-12-06 Agenda/Meeting Notes - 

Project Review

Project Proposals

• Project Proposals in Review - none to review

Project Scope Statements

• Project Scope Statements
  • [PSS-1903] Radiation Therapy Treatment Data
    • Anthony presented the project and discussed what Pharmacy's participation will be. Scott updated our input.

Discussion of MedicationKnowledge changes (Jean Duteau)

• 20 Dec 2021 - no updates

Catalog Updates (John Hatem)

• 20 Dec 2021 - Catalog minutes from
  • Dec 10 meeting:  2021-12-10 Catalog - Orders & Observations
  • Dec 17 meeting:  2021-12-17 Catalog - Orders & Observations
    • no Pharmacy specific issues; still targeting next Catalog release for May 2022

Workflow Update (John Hatem) 

• 20 Dec 2021 - Workflow minutes: 
  • FHIR Workflow Minutes CC 2021-12-13
  • No meeting this week - Dec 20th
  • No pharmacy specific issues during most recent Workflow meetings 

Healthcare Product Update (John Hatem)

• 20 Dec 2021
  • no pharmacy issues discussed. 
  • Discussed Device tracker items. 

NCPDP Updates (NCPDP Members)

• 20 Dec 2021 
  • NCPDP Task Group working on Patient Consent - for specialty prescribing
    
    • • Meeting will resume in January, 2022
  • RealTime Pharmacy Benefit Check for Consumers
    
    • • Meeting will resume in January, 2022
  • Consultant Pharmacist Task Force
    
    • • Reviewed HL7 PSS
      • Review of the 20211202 Consultant Pharmacist Consult Note document
  • Specialty Enrolment PSS (Frank/Maggie)
    • • Meeting will resume in January, 2022

Meeting information can be obtained at https://dms.ncpdp.org/

Global Supply Chain Project (Scott)

• 20 Dec 2021 

Medication List Guidance project (John)

• 20 Dec 2021 - Provided an update of current work on Dec 6th call.  Minor updates to the work completed this week.  

Projects

Pharmacy Templates

• 20 Dec 2021 - items below are carried over from last week 
  • waiting for requirements from Christof and then will decide on next steps for new version
  • Still waiting for approval of change request in Europe
    • additional elements to be added - part relationship

PDex Formulary (Corey)

• 20 Dec 2021 - items below are carried over from last week
  • Bulk Data change - not included in the next ballot
  • Updates to PSS reviewed in today's meeting by Corey
    • included non-patient specific data updates
    • minor change to reflect bulk data as an example method
  • PDEx formulary is in ballot
    • Da Vinci PDex Drug Formulary STU Balloting Dashboard

Medication List Project from EHR 

• 20 Dec 2021 
  
  • John H met with Reed last week and discussed our Med List work
  • Scott also met with Reed last week and discussed (add in here for context)
  • No new action items other than Reed's suggestion to follow the NCPDP work  
    • Will attend NCPDP meeting after the first of the year that are related to Med Rec process

Nutrition

• 20 Dec 2021 carried over from last week's meeting
  • November 17, 2021 Care Plan Topics Notes

International Patient Access

• 20 Dec 2021 - no updates

FHIR (Group)

BR&R managed resources review

• no recent meetings

New Resource - FormularyItem

• January 21 - new resource proposal deadline for May 2022 ballot

Preparation for Normative

• Melva to work with John about QA needed

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

Any Other Business

Next meeting

• 03 Jan 2022